Federal Posture Lead · Prime Lineage
Book 1 · Ch 14 · CLINs, Schedules, and Reality

Prime Relationship Status Brief

Verified open questions on who carried CHN Analytics as a sub, what vehicles they used, and why that structure shapes every CLIN conversation going forward.

1.1 · Federal Posture Lead · artifact id: prime-relationship-status-v0.html · 2026-05-28 · v0 · REAL CONTENT · GOVCON
From Shrink-Wrap It, applied to NorthAI

Ch 14 opens with the most consequential line in the book: "In federal markets, how you sell often matters as much as what you sell. The best product with the wrong acquisition structure loses to a mediocre product with the right structure." NorthAI has operated for 5.5 years inside someone else's acquisition structure. Before building its own CLIN stack, it needs to understand the structure it has been living inside and what constraints and permissions that history creates.

Headline: The prime tree is unconfirmed but the implications are concrete

Whether the OSI&A engagement ran through SOSi/Exovera, Booz Allen Hamilton, Noblis, or a non-standard vehicle, the answer changes CHN Analytics' near-term options on three dimensions: past-performance citation rights, non-compete exposure, and the fastest path to a first CHN-direct contract. This brief maps the hypothesized prime tree, scores plausibility, and isolates the three questions Tim can close in one conversation.

Hypothesized Prime Tree (Unverified)

graph LR
  OUSD["OUSD R&E / OSI&A
2018-2023
tech scouting +
intelligence analytics"] subgraph PRIME_PATH["Prime-mediated path (dominant hypothesis)"] direction TB BOOZ["Booz Allen Hamilton
RANK 1
emerging tech, OUSD
relationships, ISR depth"] NOBLIS["Noblis
RANK 2
research / analytics,
DoD-OUSD mission focus"] SAI["Strategic Analysis Inc
RANK 3
tech foresight,
defense analysis"] SOSI["SOSi / Exovera
PLAUSIBLE
ISR / OSINT fit,
no public contract link"] end CRADA["Cooperative Agreement
or CRADA
or User Agreement
(non-standard vehicle)"] CHN_SUB["CHN Analytics LLC
UEI HGMHPZK5GED3
tech scouting + R&D mapping
(subcontract scope)"] CHN_DIRECT["CHN Analytics LLC
UEI HGMHPZK5GED3
direct, no prime intermediary
(would explain zero
prime-award visibility)"] OUSD --> BOOZ OUSD --> NOBLIS OUSD --> SAI OUSD --> SOSI BOOZ --> CHN_SUB NOBLIS --> CHN_SUB SAI --> CHN_SUB SOSI --> CHN_SUB OUSD -.alternate path.-> CRADA CRADA --> CHN_DIRECT classDef source fill:#F0EEE6,stroke:#87867F,color:#3D3D3A,stroke-width:1.5px classDef rank1 fill:#E6EFFE,stroke:#3B82F6,color:#1E3A8A,stroke-width:1.5px classDef rank2 fill:#EBF1FA,stroke:#6491C7,color:#1E3A8A,stroke-width:1.5px classDef rank3 fill:#F0F4F9,stroke:#87867F,color:#3D3D3A,stroke-width:1.5px classDef plaus fill:#F8E3D6,stroke:#D97757,color:#B85C3E,stroke-width:1.5px,stroke-dasharray:5 3 classDef alt fill:#FBF7EE,stroke:#D97757,color:#B85C3E,stroke-width:1.5px,stroke-dasharray:5 3 classDef chn fill:#E5EBD9,stroke:#788C5D,color:#4F6638,stroke-width:1.5px class OUSD source class BOOZ rank1 class NOBLIS rank2 class SAI rank3 class SOSI plaus class CRADA alt class CHN_SUB,CHN_DIRECT chn

Prime Candidate Scoring

Candidate Capability Fit to OSI&A Scope Public OUSD R&E Award Evidence CHN as Sub Evidence Plausibility
Booz Allen Hamilton Strong: emerging tech briefings, ISR, OUSD relationships. ARPA-H talent support IDIQ. Broad DoD analytics footprint. No specific OUSD R&E OSI&A award found in public search. BAH holds classified task orders not visible publicly. None found RANK 1 HYPOTHESIS
Noblis Strong: research and analytics mission, DoD/OUSD focus. ARPA-H talent support IDIQ. No specific OSI&A award found. None found RANK 2 HYPOTHESIS
Strategic Analysis Inc Fit: technology foresight, defense analysis, OUSD relationships. Smaller firm; research-oriented. No specific award found. None found RANK 3 HYPOTHESIS
SOSi / Exovera Moderate: ISR, OSINT, AI/ML data fusion. Exovera (wholly-owned SOSi sub) has State Dept and DIA analytics work. Focus is ISR, not tech scouting. SOSi has OUSD R&E capability statement page but no specific contract found. No confirmed OUSD R&E awards in public search. None found PLAUSIBLE, LOWER CONFIDENCE
Cooperative Agreement / CRADA (direct) Fully consistent with R&E programs that fund external technology analysis without a prime intermediary. These vehicles do not appear in USASpending. Absence of a prime trail is consistent with this path. N/A (CHN would be direct party) EQUALLY PLAUSIBLE
Leidos / Leidos Intelligence Group Broad DoD portfolio. Intelligence programs via former IS&GS (now Leidos). Fit is possible but less targeted to tech scouting. No specific OUSD R&E OSI&A award found. None found LOW CONFIDENCE

Why This Matters for SKU Positioning

Sub-of-prime CLIN limits vs. CHN-direct GSA Schedule limits

The structural difference is significant:

The AFWERX STTR ($49,500) is CHN's only confirmed direct prime award. It is sufficient to establish past performance for SBIR Phase II applications. For GSA MAS or OASIS+ purposes, it is a thin past-performance record. The 5.5-year engagement, once the prime is identified and consent is secured, could become the primary past-performance citation.

The Booz/Leidos overlay question

If the prime was Booz Allen or Leidos and either firm has a commercial analytics or AI product that overlaps with NorthAI's offering, a non-compete clause could limit CHN's ability to sell directly into the same agency customers or even the same program offices. This is the highest-stakes unknown in this memo. It must be answered before the first SKU launch targets OUSD R&E customers specifically. If the prime is a non-competing research shop (Noblis, SAI), the risk is negligible.

Possible Overlay: Leidos/Booz Commercial Product Risk

Booz Allen Hamilton launched its AI analytics products under the "Booz Allen Dark Labs" and broader AI engineering umbrella. Leidos Intelligence Group offers data-analytics services to DoD. Neither product directly replicates NorthAI's technology scouting / RDT&E mapping capability in the unclassified space, but the overlap risk exists at the margin. The risk is low if the engagement ran through Noblis or SAI (research-only shops, no competing commercial product). The risk is moderate if the prime was Booz Allen or Leidos.

This is solvable: a sub-contract typically includes a non-compete clause that is time-limited and customer-specific. Most clauses expire 12-24 months after contract end. The OSI&A engagement ended approximately 2023. If the non-compete is customer-specific (OUSD R&E / OSI&A only), CHN can sell to other agencies immediately. Tim's review of the subcontract terms resolves this in one step.

Open Questions to Ask Tim (Next Call)

The four questions that close the prime archaeology
  1. Who was the prime contractor on the OSI&A work? Even the company name (without the contract number) lets us look up their public OUSD R&E awards and reconstruct the structure. If you signed a subcontract agreement, the prime's name is on page 1.
  2. Does the subcontract have a non-compete clause, and if so, what does it cover? Scope (customers? capabilities? geographies?) and duration. This directly determines which agency customers are available for CHN's first direct SKU launch.
  3. Did the prime authorize past-performance citation? Some vehicles require a past-performance consent form. If consent was pre-authorized in the subcontract, no additional step is needed. If not, this is a one-email ask to the prime's contracts team.
  4. Was any part of the OSI&A work under a cooperative agreement, CRADA, or user agreement rather than a standard prime-sub subcontract? If yes, CHN may be the direct party of record, which changes the past-performance citation picture entirely (no prime consent needed).

How Phase III Changes the Prime-Sub Calculus

Phase III sole-source authority routes around the prime-sub structure for derived-extended-or-completed work. That changes which prime relationships still earn the time investment. Sponsorship (CO relationship support) still matters; competed-RFP partnership does not.

Booz Allen Hamilton (R1)

Still matters. As an existing prime to OPD-DE and DIB policy programs, Booz could sponsor the CO relationship for Phase III and become the routing partner without holding the contract directly. The Booz connection is worth maintaining even if Phase III bypasses the traditional sub arrangement.

Noblis (R2)

Mixed. Strong FFRDC-adjacent technical credibility helps Phase III memo defensibility, but Noblis is not a procurement vehicle -- Phase III contracts route directly to CHN. Useful as a reference node, not as a contracting channel.

Strategic Analysis Inc (R3)

Lower importance. SAI's value was as a competed-RFP partner. Under Phase III, that path is bypassed and SAI holds no CO sponsorship weight with the relevant program offices.

SOSi / Exovera (PLAUSIBLE)

Lower importance. Same logic as SAI -- Phase III routes around competed-prime arrangements. SOSi's ISR and OSINT footprint does not translate to CO relationship sponsorship for the OUSD R&E mission that Phase III would target.